Michel Maillard

1.1k total citations
16 papers, 698 citations indexed

About

Michel Maillard is a scholar working on Molecular Biology, Organic Chemistry and Physiology. According to data from OpenAlex, Michel Maillard has authored 16 papers receiving a total of 698 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Organic Chemistry and 5 papers in Physiology. Recurrent topics in Michel Maillard's work include Adenosine and Purinergic Signaling (5 papers), HIV Research and Treatment (4 papers) and HIV/AIDS drug development and treatment (4 papers). Michel Maillard is often cited by papers focused on Adenosine and Purinergic Signaling (5 papers), HIV Research and Treatment (4 papers) and HIV/AIDS drug development and treatment (4 papers). Michel Maillard collaborates with scholars based in United States, United Kingdom and France. Michel Maillard's co-authors include Kenneth A. Jacobson, Carola Gallo‐Rodriguez, Bilha Fischer, Olga Nikodijević, William L. Padgett, John W. Daly, Geoffrey Burnstock, Yishai Karton, Philip J. M. van Galen and Andrew Van Bergen and has published in prestigious journals such as Journal of Molecular Biology, FEBS Letters and Journal of Medicinal Chemistry.

In The Last Decade

Michel Maillard

16 papers receiving 675 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michel Maillard United States 12 368 366 191 103 85 16 698
Philip J. M. van Galen United States 16 723 2.0× 610 1.7× 400 2.1× 187 1.8× 68 0.8× 21 1.1k
Anke C. Schiedel Germany 21 541 1.5× 713 1.9× 168 0.9× 272 2.6× 41 0.5× 47 1.2k
G. Cristalli Italy 17 568 1.5× 543 1.5× 208 1.1× 193 1.9× 36 0.4× 66 924
Sheryl J. Hays United States 17 329 0.9× 700 1.9× 468 2.5× 280 2.7× 94 1.1× 37 1.3k
Heidi Figler United States 14 454 1.2× 370 1.0× 275 1.4× 134 1.3× 26 0.3× 16 810
Liaman Mamedova United States 10 326 0.9× 343 0.9× 96 0.5× 105 1.0× 63 0.7× 12 538
Ji-long Jiang United States 10 555 1.5× 424 1.2× 296 1.5× 150 1.5× 30 0.4× 10 809
Suhaib M. Siddiqi United States 16 466 1.3× 613 1.7× 335 1.8× 82 0.8× 28 0.3× 23 938
Xiao-duo Ji United States 9 515 1.4× 428 1.2× 194 1.0× 115 1.1× 29 0.3× 9 682
Bernard R. Neustadt United States 16 194 0.5× 366 1.0× 335 1.8× 117 1.1× 12 0.1× 26 773

Countries citing papers authored by Michel Maillard

Since Specialization
Citations

This map shows the geographic impact of Michel Maillard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michel Maillard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michel Maillard more than expected).

Fields of papers citing papers by Michel Maillard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michel Maillard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michel Maillard. The network helps show where Michel Maillard may publish in the future.

Co-authorship network of co-authors of Michel Maillard

This figure shows the co-authorship network connecting the top 25 collaborators of Michel Maillard. A scholar is included among the top collaborators of Michel Maillard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michel Maillard. Michel Maillard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Luckhurst, Christopher A., Omar Aziz, Vahri Beaumont, et al.. (2018). Development and characterization of a CNS-penetrant benzhydryl hydroxamic acid class IIa histone deacetylase inhibitor. Bioorganic & Medicinal Chemistry Letters. 29(1). 83–88. 38 indexed citations
2.
Maillard, Michel, Celia Dominguez, Mark J. Gemkow, et al.. (2013). A Label-Free LC/MS/MS-Based Enzymatic Activity Assay for the Detection of Genuine Caspase Inhibitors and SAR Development. SLAS DISCOVERY. 18(8). 868–878. 3 indexed citations
3.
Maillard, Michel, Frederick A. Brookfield, Stephen M. Courtney, et al.. (2011). Exploiting differences in caspase-2 and -3 S2 subsites for selectivity: Structure-based design, solid-phase synthesis and in vitro activity of novel substrate-based caspase-2 inhibitors. Bioorganic & Medicinal Chemistry. 19(19). 5833–5851. 29 indexed citations
4.
Müller, Ilka, Marieke Lamers, Alison J. Ritchie, et al.. (2011). A New Apo-Caspase-6 Crystal Form Reveals the Active Conformation of the Apoenzyme. Journal of Molecular Biology. 410(2). 307–315. 12 indexed citations
5.
Maillard, Michel, Roy K. Hom, Timothy E. Benson, et al.. (2007). Design, Synthesis, and Crystal Structure of Hydroxyethyl Secondary Amine-Based Peptidomimetic Inhibitors of Human β-Secretase. Journal of Medicinal Chemistry. 50(4). 776–781. 83 indexed citations
6.
Maillard, Michel, Michael E. Perlman, James B. Fischer, et al.. (1998). Design, Synthesis, and Pharmacological Evaluation of Conformationally Constrained Analogues of N,N‘-Diaryl- and N-Aryl-N-aralkylguanidines as Potent Inhibitors of Neuronal Na+ Channels. Journal of Medicinal Chemistry. 41(16). 3048–3061. 41 indexed citations
7.
Adams, David R., Michel Maillard, Jean‐Claude Florent, et al.. (1997). Preparation and Anti-HIV Activity of N-3-Substituted Thymidine Nucleoside Analogs. Journal of Medicinal Chemistry. 40(10). 1550–1558. 21 indexed citations
8.
Burnstock, Geoffrey, Bilha Fischer, Charles H.V. Hoyle, et al.. (1994). Structure activity relationships for derivatives of adenosine‐5′‐triphosphate as agonists at P2 purinoceptors: Heterogeneity within P2x and P2y subtypes. Drug Development Research. 31(3). 206–219. 83 indexed citations
9.
Maillard, Michel, Olga Nikodijević, Kathryn F. LaNoue, et al.. (1994). Adenosine Receptor Prodrugs: Synthesis and Biological Activity of Derivatives of Potent, ArSelective Agonists. Journal of Pharmaceutical Sciences. 83(1). 46–53. 21 indexed citations
10.
Bo, Xuenong, Bilha Fischer, Michel Maillard, Kenneth A. Jacobson, & Geoffrey Burnstock. (1994). Comparative studies on the affinities of ATP derivatives for P2X‐purinoceptors in rat urinary bladder. British Journal of Pharmacology. 112(4). 1151–1159. 57 indexed citations
11.
Jacobson, Kenneth A., Carola Gallo‐Rodriguez, Neli Melman, et al.. (1993). Structure-activity relationships of 8-styrylxanthines as A2-selective adenosine antagonists. Journal of Medicinal Chemistry. 36(10). 1333–1342. 121 indexed citations
12.
Jacobson, Kenneth A., Olga Nikodijević, William L. Padgett, et al.. (1993). 8‐(3‐Chlorostyryl)caffeine (CSC) is a selective A2‐adenosine antagonist in vitro and in vivo. FEBS Letters. 323(1-2). 141–144. 150 indexed citations
13.
Faraj, Achraf Al, Michel Maillard, Marc Lemaître, et al.. (1992). Synthesis and evaluation of new 2′,3′-dideoxynucleoside analogs as potential anti-AIDS and anti-herpes drugs. European Journal of Medicinal Chemistry. 27(2). 141–148. 6 indexed citations
14.
Maillard, Michel, Jean‐Claude Florent, Marc Lemaître, et al.. (1992). Preparation and anti-HIV activity of N-3 amino substituted thymidine nucleoside analogs. Bioorganic & Medicinal Chemistry Letters. 2(12). 1469–1474. 3 indexed citations
15.
Maillard, Michel, et al.. (1991). PHOTOLABILE A1-ADENOSINE RECEPTOR AGONISTS AS "CAGED" ELECTROPHYSIOLOGICAL PROBES.. PubMed. 1. 322–329. 1 indexed citations
16.
Maillard, Michel, Abdesslem Faraj, François Frappier, et al.. (1989). Synthesis of 3′-substituted-2′,3′-dideoxynucleoside analogs as potential anti-aids drugs. Tetrahedron Letters. 30(15). 1955–1958. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Philip J. M. van Galen Breakdown of academic impact, for papers by Anke C. Schiedel Breakdown of academic impact, for papers by G. Cristalli Breakdown of academic impact, for papers by Sheryl J. Hays Breakdown of academic impact, for papers by Heidi Figler Breakdown of academic impact, for papers by Liaman Mamedova Breakdown of academic impact, for papers by Ji-long Jiang Breakdown of academic impact, for papers by Suhaib M. Siddiqi Breakdown of academic impact, for papers by Xiao-duo Ji Breakdown of academic impact, for papers by Bernard R. Neustadt
Rankless by CCL
2026